Vivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & Sullivan 
Jupiter Wellness Enters into Letter of Intent to Acquire JustCBD and its Affiliates
Accretive acquisition would add a profitable company with approximately $28 million of revenue in 2020 (unaudited) JUPITER, FL / ACCESSWIRE...
AngioSoma, Inc. Adds David Croom As Executive Vice President
Croom's Experience in Finance, Sales, and Operations Will Play a Key Role in the Growth of AngioSoma RICHLAND, WA /...
Technology Giants Flock to Healthcare Arena; MediXall Group Targets Additional Acquisitions
FORT LAUDERDALE, FL / ACCESSWIRE / April 20, 2021 / MediXall Group, Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, announced today that...
Thermal Energy International to Present at the Planet MicroCap Showcase: VIRTUAL on Wednesday, April 21, 2021
OTTAWA, ON / ACCESSWIRE / April 20, 2021 / Thermal Energy International Inc. ("Thermal Energy" or the "Company") (TSX.V:TMG), an...
MagicMed Industries to present at the Planet MicroCap Showcase: Virtual on April 22nd
CALGARY, AB / ACCESSWIRE / April 20, 2021 / MagicMed Industries Inc. ("MagicMed" or the "Company"), a biotechnology company focused...
Ripple Therapeutics Announces First Patient Treated in Phase II Trial Evaluating IBE-814 IVT in DME and RVO
TORONTO, ON / ACCESSWIRE / April 20, 2021 / Ripple Therapeutics Corporation ("Ripple"), a clinical stage, ophthalmology-focused developer of novel...
A Joint Venture: CLS Branded Division, City Trees, Partners with Renowned Nevada Cultivator in Exclusive Collaboration
LAS VEGAS, NV / ACCCESSWIRE / April 20, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
Purisys will supply ultra-high purity cannabinoids for use in GB Sciences' cannabinoid-containing, optimized therapeutic mixtures (OTM). LAS VEGAS, NV /...
T3D Therapeutics, Inc.: T3D Therapeutics Announces First Patient Dosed in its Phase 2 Study of T3D-959 for the Treatment of Mild to Moderate Alzheimer’s Disease
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 20, 2021 / T3D Therapeutics, Inc. ("T3D"), a clinical stage drug development...
Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis
DURHAM, NC / ACCESSWIRE / April 20, 2021 / Baebies, a growth-stage company developing innovative products to enable early disease...
Bespoke Extracts Teams with LEAF411, The First Free Cannabis Nurse Hotline
Leaf 411 Powered by Leaf Nurse Network SUNNY ISLES, Fla., April 20, 2021 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC...
BioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board Members
Pompano Beach, Fl., April 20, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a...
Allied Corp. Announces Clearance From the Colombian Authorities to Export Cannabis Products Internationally
KELOWNA, British Columbia, April 20, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on...
Entera Announces Ron Mayron, a Global Pharma Leader, Joins its Board of Directors
BOSTON and JERUSALEM, April 20, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of...
Healthy Extracts Inc. (OTCQB: HYEX) Announces the Addition of Dr. Joel Kahn, Renowned Integrative Cardiologist, to Its Medical Board
Kahn Center for Cardiac Longevity CIMT tests show positive results in arterial age reversal and cardiovascular benefts with BergametNA Citrus...
LEXEO Therapeutics Announces FDA Fast Track Designation Granted to LX1001 for the Treatment of APOE4 Associated Alzheimer’s Disease
LX1001 is the first investigational gene therapy being evaluated to address the underlying genetics of Alzheimer’s disease Initial Phase 1...
Better Choice Announces 19% Growth in Q1 2021 Gross Sales Relative to Q4 2020 Gross Sales
NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6
FARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices...
Innovative MedTech Announces New Stock Trading Symbol – IMTH – and Provides Corporate Update
BLUE ISLAND, Ill., April 20, 2021 (GLOBE NEWSWIRE) -- Innovative MedTech, Inc. (the "Company") (OTC: IMTH), a provider of health and...